European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic

Ciavattini, Andrea; Carpini, Giovanni Delli; Giannella, Luca; Arbyn, Marc; Kyrgiou, Maria; Joura, Elmar A.; Sehouli, Jalid; Carcopino, Xavier; Redman, C. W. E.; Nieminen, Pekka; Cruickshank, Margaret; Gültekin, Murat

doi:10.1136/ijgc-2020-001617

Cited by 38 publications

(58 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, the current COVID-19 pandemic may exacerbate any existing problems with equity in vaccination [ 25 ]. During the COVID-19 pandemic, HPV vaccination programs are delayed in countries with clusters of cases and/or community transmission of COVID-19 to minimize the spread of infection [ 26 ]. People whose initiation of HPV vaccination has been delayed or whose vaccination schedule has been interrupted due to the COVID-19 pandemic may experience a decrease in vaccination intention during that period.…”

Section: Discussionmentioning

confidence: 99%

Examining Long-Term Effects of Human Papillomavirus Vaccine Recommendation Messages: A 4-Month Follow-Up Survey of a Randomized Controlled Study in Japan

et al. 2020

View full text Add to dashboard Cite

We previously conducted a randomized controlled study to examine persuasive messages recommending HPV vaccination to mothers with daughters in Japan. That study showed that the three types of intervention message used (statistical information only, a patient’s narrative in addition to statistical information, and a mother’s narrative in addition to statistical information) all significantly improved mothers’ intention to have their daughter(s) receive the HPV vaccine, in comparison with mothers who received no messaging. The present study is a follow-up survey to assess the long-term effect of the intervention. Four months after the initial study, in January 2018, participants in the previous study were contacted and queried about their current intention to have their daughter(s) receive the HPV vaccine. Statistical analysis was conducted using the paired t-test and analysis of variance. A total of 978 mothers participated in the current survey. Vaccination intention 4 months after intervention had decreased to a level that did not differ significantly from the level prior to intervention in all three intervention conditions. The amount of change in vaccination intention 4 months after intervention did not differ significantly among the three intervention groups (p = 0.871). A single exposure to messaging was insufficient to produce a persistent intervention effect.

show abstract

Section: Discussionmentioning

confidence: 99%

Examining Long-Term Effects of Human Papillomavirus Vaccine Recommendation Messages: A 4-Month Follow-Up Survey of a Randomized Controlled Study in Japan

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The present situation has disrupted the vaccination and screening programs even in developed countries because of border closures, mass level lockdown, and disruption in flights, transportation and human resource services. [5][6][7][8] This might increase the risk of developing cervical cancer in women, which is a public health concern. [5][6][7][8] Therefore, many experts have suggested some options for the management of cervical cancer during the COVID-19 pandemic.…”

Section: Gynecological Cancermentioning

confidence: 99%

“…[5][6][7][8] This might increase the risk of developing cervical cancer in women, which is a public health concern. [5][6][7][8] Therefore, many experts have suggested some options for the management of cervical cancer during the COVID-19 pandemic. [5][6][7][8] While COVID-19 is a threat to public health systems, it is also an opportunity to reform the health sectors for betterment of human beings.…”

Section: Gynecological Cancermentioning

confidence: 99%

“…[5][6][7][8] Therefore, many experts have suggested some options for the management of cervical cancer during the COVID-19 pandemic. [5][6][7][8] While COVID-19 is a threat to public health systems, it is also an opportunity to reform the health sectors for betterment of human beings. There is an immediate need to start, or continue with, community-based HPV vaccination and cervical screening test programs among women in LMICs if there is to be a reduction in the prevalence of, and morality from, cervical cancer.…”

Section: Gynecological Cancermentioning

confidence: 99%

See 1 more Smart Citation

Effective approaches towards eliminating cervical cancer from low-and middle-income countries amid COVID-19 pandemic

Rahman

Gültekin

Lassi

2020

Int J Gynecol Cancer

Self Cite

View full text Add to dashboard Cite

“…Sometimes, this happens because a large proportion of the population is lost to cervical cancer screening due to poor resources, cultural barriers, or avoidance of a pelvic exam [ 1 ]. Additionally, sometimes these women live in low-resource settings or belong to social or religious minorities; however, a considerable percentage of cervical screening non-attenders simply feel uncomfortable with the current screening protocols and methodology, including visiting health facilities, more so during the COVID-19 pandemic, and/or trying to avoid the gynecological examination and the lithotomy position [ 2 , 3 ].…”

Section: Introductionmentioning

confidence: 99%

Urine HPV in the Context of Genital and Cervical Cancer Screening—An Update of Current Literature

Daponte¹,

Michail

Daponte³

et al. 2021

Cancers

View full text Add to dashboard Cite

Within the previous decades, following the widespread implementation of HPV-related biomarkers and computerization in liquid-based cytology, screening for lower genital tract malignancies has been optimized in several parts of the world. Many organized anogenital cancer prevention systems have reached a point at which efficacy is more a matter of population coverage and less of available infrastructures. Meanwhile, self-sampling modalities in which biologic material (vaginal secretions, urine, etc.) is obtained by the individual and not the clinician and subsequently undergoes examination for HPV biomarkers enjoy appreciating acceptance. Bygone the initial skepticism that vaginal or urine HPV represents “passenger” transient infections, extensive scientific work has been conducted to optimize high-risk HPV (hrHPV) detection from this “novel” biologic material. Nowadays, several state-of-the-art meta-analyses have illustrated that self-sampling techniques involving urine self-sampling represent a feasible alternative strategy with potentially enhanced population coverage possessing excellent performance and sensitivity. Recently published scientific work focusing on urine HPV was reviewed, and after a critical appraisal, the following points should be considered in the clinical application of hrHPV urine measurements; (i) use of first-void urine (FVU) and purpose-designed collection devices; (ii) using a preservation medium to avoid human/HPV DNA degradation during extraction and storage; (iii) using polymerase chain reaction (PCR) based assays, ideally with genotyping capabilities; (iv) processing of a sufficient volume of whole urine; and (v) the use of an analytically sensitive HPV test/recovery of cell-free HPV DNA in addition to cell-associated DNA.

show abstract

European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic

Cited by 38 publications

References 8 publications

Examining Long-Term Effects of Human Papillomavirus Vaccine Recommendation Messages: A 4-Month Follow-Up Survey of a Randomized Controlled Study in Japan

Examining Long-Term Effects of Human Papillomavirus Vaccine Recommendation Messages: A 4-Month Follow-Up Survey of a Randomized Controlled Study in Japan

Effective approaches towards eliminating cervical cancer from low-and middle-income countries amid COVID-19 pandemic

Urine HPV in the Context of Genital and Cervical Cancer Screening—An Update of Current Literature

Contact Info

Product

Resources

About